FIELD: pharmaceutical industry. SUBSTANCE: described are new substituted benzoyl guanidines of formula I: wherein R(1) is hydrogen or R(5)-Som; m is 0,1 or 2; R(5) is (C1-C8) alkyl; R(2) is -CF2R(14),-CF[R(15)][R(16)]6; R(14) is (C1-C4) alkyl; R(15) and R(16) are independently hydrogen or (C1-C4) alkyl; R(3) is defined as R(1); R(4) is hydrogen, -(CH2)5-(CF2)t-CF3; S is 0 or 1; t is 0,1 or 2, and also pharmaceutically tolerable salts thereof. Said compounds are exceptional agents for treating diseases of heart circulation system. Also described are method of preparing compounds of formula I, inhibition method of pharmaceutical agent. EFFECT: improved properties of the title compounds. 9 cl
Title | Year | Author | Number |
---|---|---|---|
BENZOYLGUANIDINES, METHOD OF PREPARATION THEREOF, INTERMEDIATES FOR THEIR PREPARATION, INHIBITION METHOD, AND DRUG | 1995 |
|
RU2160727C2 |
ORTHO-SUBSTITUTED BENZOYLGUANIDINES AND MEDICINAL AGENTS CONTAINING THEREOF | 1997 |
|
RU2212400C2 |
ORTHO-SUBSTITUTED BENZOYLGUANIDINES AND MEDICINAL AGENT BASED ON THEREOF | 1997 |
|
RU2193025C2 |
ORTHO-SUBSTITUTED BENZOYLGUANIDINES AND MEDICINAL AGENT BASED ON THEREOF | 1997 |
|
RU2214397C2 |
BASE-SUBSTITUTED BENZOYLGUANIDINES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF ITS PREPARING AND METHOD OF INHIBITION OF CELLULAR Na/H-ANTIPORTER | 1996 |
|
RU2161604C2 |
AMINOACID-SUBSTITUTED BENZOYL GUANIDINES METHOD OF PREPARATION THEREOF, METHOD OF INHIBITING CELLULAR Na/H-ION EXCHANGE, AND MEDICINAL AGENT | 1995 |
|
RU2154055C2 |
BENZOYLGUANIDINES, METHOD OF THEIR SYNTHESIS, METHOD OF INHIBITION, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1996 |
|
RU2165412C2 |
SULFONEIMIDEAMIDES, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1996 |
|
RU2180658C2 |
AMINO-SUBSTITUTED BENZOYLGUANIDINES AND METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2085555C1 |
THIOPHENYLALKENYL CARBOXYLIC ACID SUBSTITUTED GUANIDIDES AND MEDICINAL AGENT | 1997 |
|
RU2193033C2 |
Authors
Dates
2000-11-27—Published
1995-09-07—Filed